Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.06.2012 | Clinical study

Hepatotoxicity more likely with atorvastatin vs simvastatin

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

Atorvastatin is shown to be associated with an overall higher risk of hepatotoxicity than simvastatin in analyses conducted by investigators from the UK. …
Literatur
1.
Zurück zum Zitat Clarke AT, Johnson PCD, Hall GC, Ford I, Mills PR.High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin: a retrospective cohort study using the UK General Practice Research Database. 47th Annual Meeting of the European Association for the Study of the Liver: abstr. 1343, 18 Apr 2012. Available from: URL: http://mobile.ilcapp.eu/easl%5f161/poster%5f24709/program.aspx Clarke AT, Johnson PCD, Hall GC, Ford I, Mills PR.High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin: a retrospective cohort study using the UK General Practice Research Database. 47th Annual Meeting of the European Association for the Study of the Liver: abstr. 1343, 18 Apr 2012. Available from: URL: http://​mobile.​ilcapp.​eu/​easl%5f161/​poster%5f24709/​program.​aspx
Metadaten
Titel
Hepatotoxicity more likely with atorvastatin vs simvastatin
Publikationsdatum
01.06.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214060-00011

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Dapsone

Case report

Thiamazole

Case report

Cytarabine

Case report

Zoledronic acid